upcoming catalysts sept-oct 2013

The following could be exciting positive catalysts for Sunshine Heart from now till the end of the year , for any new members/investors , this could be helpful , also to older investors , these dates will hopefully be pivotal

September 26 + October 28




September 26

German HF Society Meeting

The first three month patient follow up is expected in August. The initial release of results is targeted at the September 26(th) German Heart Failure Society meeting.

October 28

TCT Conference

Two additional patients have been identified as potential candidates for weaning from the therapy. Sunshine Heart expects to release full weaning data to-date at the 2013 Transcatheter Cardiovascular Therapeutics (TCT) conference at the end of October.


Reimbursement application + Fully implantable news

So this is also going to help us apply for reimbursement at the end of October for Germany this year and also generate some continued interest just in the company because in fact our first release of results is going to be at the TCT meeting in October. And I think it is, I believe, it’s October 28. When are we going to announcing those results and while we are on the call, I’ll find out what time but we’ve already got a slide presentation. [Dr. Jean Schmidto] from Hanover in Germany is going to be doing the initial presentation.

Every year at TCT, we’ve had an investor/analyst breakfast session. And last year, we presented our one-year data there and also had a discussion about the fully implantable system trial. We had two different doctors do those presentations.

And this year the one that will have during the course of the day at the heart-failure session will be [Dr. Schmidto] and then we’re planning on doing is including him also at the investor session and having a second and maybe third meeting. The second talk would be on weaning progress and then the third one, could be on any of the results of our fully implantable system. We’re going to be some acute trial before we start the chronic trial in Q4. So there maybe three, when all set and done